Tetracycline Hydrochloride Capsules
In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 1 Expert Committee has revised the monograph for Tetracycline Hydrochloride Capsules. The purpose for the revision is to include a dissolution test for a product approved by FDA.
The Tetracycline Hydrochloride Capsules Revision Bulletin supersedes the currently official monograph.
The Revision Bulletin will be incorporated in the First Supplement to USP 34–NF 29.
Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or email@example.com).